A 38-year-old man developed atypical hemolytic uremic syndrome (aHUS) and end-stage kidney disease (ESKD) after receiving his first dose…
Patricia Valerio, PhD
Patricia holds a PhD in Neurobiology from the University of Basel, Switzerland, where she studied how hearing develops and functions. She is originally from Portugal and earned an MSc in Cellular and Molecular Biology, focusing on metabolic diseases, such as diabetes, and a BSc in Biomedical Pharmacy from the University of Coimbra. Patricia enjoys communicating science to inspire, educate and help different audiences understand its complexity and relevance.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Patricia Valerio, PhD
A 68-year-old man was diagnosed with atypical hemolytic uremic syndrome (aHUS) that, in…
Soliris(eculizumab) was found to be effective in most patients with atypical hemolytic…